Navigation Links
Shift work and cancer

Shift work can cause cancer. In the new issue of the Deutsches rzteblatt International (Dtsch Arztebl Int 2010; 107[38]: 657-62), Thomas C. Erren and colleagues describe the current state of knowledge in this area and point out the challenges lying ahead.

Although it is well known that short-term disturbances of circadian rhythms, such as jet lag, can impair a person's sense of well-being, researchers only recently began to ask whether chronic disruption of biological rhythms over the long term might promote cancer. The possibility of financial compensation in such cases is already an immediately relevant political issue: in 2008, 38 women in Denmark who had worked the night shift and then developed breast cancer obtained official recognition of their disease as an occupational illness and were awarded compensation for it. The findings of the laboratory experiments performed to date in animals and cell preparations lend plausibility to the postulated link between shift work and cancer, yet there is still no answer to the central question whether these findings are applicable to humans. Even though the connection between shift work and cancer has not yet been definitively established, the authors make a case for recasting old-fashioned shift-work schedules in the light of recently gained insights from occupational medicine and chronobiology.


Contact: Thomas C. Erren
Deutsches Aerzteblatt International

Page: 1

Related medicine news :

1. Drugs That Shift Cells Energy Find New Purpose
2. Poll: Nurses Spend a Quarter of Shift on Non-patient Care
3. Shift Work Can Put a Crimp on Sleep
4. Shift workers at more risk for irritable bowel syndrome, U-M study says
5. Shift Work Linked to Irritable Bowel Syndrome
6. Getting heavier, younger: U-M study shows generational shift in obesity
7. Hospital Cost Shifting Adds to Auto Injury Claim Costs
8. New Finding Could Mark Shift in Alzheimers Research
9. Caffeine Helps Shift Workers Avoid Mistakes
10. The best and worst work schedules: Shift start times can impact sleep and alertness
11. Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities
Post Your Comments:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: